Clinical Trials in Houston

Showing 12741-12760 of 15,366 trials

A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

NCT00679991

PRT-201 is a protein that causes long lasting dilation of blood vessels when applied to the outside surface of the blood vessel. The purpose of this study is to determine if PRT-201, when applied to a limited segment of blood vessel immediately after surgery to create an arteriovenous fistula (AVF), is safe, dilates the blood vessel, and increases blood flow through the AVF.

Chronic Kidney Disease

Proteon Therapeutics66 participantsStarted Nov 2008

Indianapolis, Indiana, United States • Iowa City, Iowa, United States • Portland, Maine, United States +8 more locations

COMPLETEDPhase 1< 1 mile

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

NCT00005057

RATIONALE: Inserting a modified herpesvirus gene into a person's melanoma cells may make the cancer more sensitive to the antiviral agent ganciclovir. PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have stage IV melanoma.

Melanoma (Skin)

National Human Genome Research Institute (NHGRI)Started Mar 2000

Bethesda, Maryland, United States • Bethesda, Maryland, United States • Houston, Texas, United States

A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Find Trials by Condition in Houston

Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia

CSP #512 - Options in Management With Anti-Retrovirals

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)

CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness

A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

Effect of Teriparatide on Hip Fracture Healing

Dose Escalation of IPI-493 in Hematologic Malignancies

A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults

Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)